Alejandro González Veliz: Beyond the Golden Hour in Stroke Care
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn:
“The stroke clock is still critical – but it is no longer the whole story.
This 2026 review highlights how acute ischemic stroke management has evolved from a primarily time-driven approach toward increasingly sophisticated tissue- and patient-selection strategies.
Tenecteplase is expanding the thrombolysis landscape.
Advanced imaging can identify selected patients who may benefit beyond traditional treatment windows.
Mechanical thrombectomy has moved well beyond the original early-window large-vessel population, with growing evidence even in patients with large ischemic cores.
At the same time, important questions remain – particularly for medium and distal vessel occlusions.
The central message is simple:
Treat fast.
Image intelligently.
Select carefully.”
Other posts featuring Alejandro González Veliz on Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?